IP vs ZBIO · P/E 43, $26.62B cap vs rev $5.0M
International Paper (IP) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported ZBIO revenue for 2024-12-31 was $5.0M. Net income was -$157.0M. Revenue was down 90.0% from 2023-12-31 to 2024-12-31. ZBIO currently screens at market cap $798.0M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the IP and ZBIO stock pages for the full models.
Not investment advice.